Home > Financial Ratios > NEULAND LABORATORIES

NEULAND LABORATORIES
Working Capital/Sales

    Back to All Ratios
NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for NEULAND LABORATORIES
Please provide your vote to see the results

NEULAND LABORATORIES Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Working Capital/Sales(x) 2.622.193.163.704.37

What is the latest Working Capital/Sales ratio of NEULAND LABORATORIES ?

The latest Working Capital/Sales ratio of NEULAND LABORATORIES is 2.62 based on Mar2026 Consolidated results.
Year Working Capital/Sales
Mar20262.62
Mar20252.19
Mar20243.16
Mar20233.70
Mar20224.37

How is Working Capital/Sales of NEULAND LABORATORIES Trending?

Years Working Capital/Sales % Change
Mar2026 2.62
19.63
Mar2025 2.19
-30.70
Mar2024 3.16
-14.59
Mar2023 3.7
-15.33
Mar2022 4.37 -

Other Financial Ratios of NEULAND LABORATORIES


Compare Working Capital/Sales ratio of peers of NEULAND LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NEULAND LABORATORIES ₹24,673.2 Cr 1.9% -10.1% 23.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹422,991.0 Cr 1.1% -4.2% 4.1% Stock Analytics
DIVIS LABORATORIES ₹256,310.0 Cr 7.5% 1.3% 45.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹173,604.0 Cr 1.8% -6.3% 26.1% Stock Analytics
DR REDDYS LABORATORIES ₹111,722.0 Cr 9.3% 9.5% 4.3% Stock Analytics
CIPLA ₹109,628.0 Cr 1.5% -2.3% -17.3% Stock Analytics


NEULAND LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NEULAND LABORATORIES

1.9%

-10.1%

23.6%

SENSEX

1.2%

0.4%

-12.2%


You may also like the below Video Courses